Smith & Nephew SNATS (NYSE:SNN) Sees Unusually-High Trading Volume - Still a Buy?

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) saw an uptick in trading volume on Tuesday . 1,235,455 shares traded hands during mid-day trading, an increase of 52% from the previous session's volume of 811,189 shares.The stock last traded at $29.69 and had previously closed at $29.17.

Analyst Upgrades and Downgrades

A number of brokerages have commented on SNN. Hsbc Global Res cut shares of Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. UBS Group cut shares of Smith & Nephew SNATS from a "buy" rating to a "neutral" rating in a report on Wednesday, March 12th. HSBC cut Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a research note on Friday, April 25th. Finally, Canaccord Genuity Group raised their price target on Smith & Nephew SNATS from $27.00 to $28.00 and gave the stock a "hold" rating in a research note on Thursday, May 1st. Six investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $28.00.

Smith & Nephew SNATS Stock Up 0.1%

The stock has a market cap of $13.25 billion, a PE ratio of 14.00, a price-to-earnings-growth ratio of 0.92 and a beta of 0.68. The business has a fifty day moving average of $28.58 and a 200-day moving average of $27.06. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.89 and a quick ratio of 1.33.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Principal Securities Inc. lifted its position in Smith & Nephew SNATS by 87.6% during the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 691 shares during the period. Sanctuary Advisors LLC lifted its position in Smith & Nephew SNATS by 7.8% during the fourth quarter. Sanctuary Advisors LLC now owns 24,904 shares of the medical equipment provider's stock worth $639,000 after buying an additional 1,810 shares in the last quarter. Hara Capital LLC grew its holdings in shares of Smith & Nephew SNATS by 391.4% in the fourth quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock valued at $60,000 after purchasing an additional 1,957 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in Smith & Nephew SNATS by 126.0% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 38,913 shares of the medical equipment provider's stock worth $956,000 after buying an additional 21,695 shares in the last quarter. Finally, US Bancorp DE increased its position in shares of Smith & Nephew SNATS by 21.8% during the fourth quarter. US Bancorp DE now owns 13,604 shares of the medical equipment provider's stock worth $334,000 after acquiring an additional 2,437 shares during the period. Institutional investors own 25.64% of the company's stock.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.